Pratik B Shah1, Manpreet Samra2, Michelle A Josephson3. 1. Section of Nephrology, University of Chicago Medicine, Chicago, IL, USA. 2. Division of Nephrology, University of Illinois at Chicago, Chicago, IL, USA. 3. Section of Nephrology, University of Chicago Medicine, Chicago, IL, USA. mjosephs@medicine.bsd.uchicago.edu.
Abstract
PURPOSE OF REVIEW: To review the studies and practice guidelines on the preeclampsia risks in kidney donors and recipients. RECENT FINDINGS: There is a small increased risk of gestational hypertension and preeclampsia in pregnancies that follow kidney donation. Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guideline (2017) and the 2015 American Society of Transplantation (AST) consensus conference statement recommends counseling kidney donors about this increased risk. There is no observed increase in fetal complications or eclampsia post-kidney donation. Preeclampsia is more commonly observed in kidney transplant recipients than the general population and these patients should be co-managed with an obstetrician with experience in managing high risk pregnancies. Although preeclampsia has not been found to have a deleterious effect on renal graft function, it can cause premature delivery. Risk calculators have been proposed and an elevated pre-pregnancy creatinine seems to be an important risk. KDIGO Clinical Practice Guidelines (2009) recommends attempting pregnancy when kidney function is stable with proteinuria of less than 1 g per day. The use of novel biomarkers for preeclampsia has not been published in this population. Preeclampsia is an important concern for female kidney donors and recipients of child-bearing age. These individuals should be appropriately counseled.
PURPOSE OF REVIEW: To review the studies and practice guidelines on the preeclampsia risks in kidney donors and recipients. RECENT FINDINGS: There is a small increased risk of gestational hypertension and preeclampsia in pregnancies that follow kidney donation. Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guideline (2017) and the 2015 American Society of Transplantation (AST) consensus conference statement recommends counseling kidney donors about this increased risk. There is no observed increase in fetal complications or eclampsia post-kidney donation. Preeclampsia is more commonly observed in kidney transplant recipients than the general population and these patients should be co-managed with an obstetrician with experience in managing high risk pregnancies. Although preeclampsia has not been found to have a deleterious effect on renal graft function, it can cause premature delivery. Risk calculators have been proposed and an elevated pre-pregnancy creatinine seems to be an important risk. KDIGO Clinical Practice Guidelines (2009) recommends attempting pregnancy when kidney function is stable with proteinuria of less than 1 g per day. The use of novel biomarkers for preeclampsia has not been published in this population. Preeclampsia is an important concern for female kidney donors and recipients of child-bearing age. These individuals should be appropriately counseled.
Authors: D LaPointe Rudow; R Hays; P Baliga; D J Cohen; M Cooper; G M Danovitch; M A Dew; E J Gordon; D A Mandelbrot; S McGuire; J Milton; D R Moore; M Morgievich; J D Schold; D L Segev; D Serur; R W Steiner; J C Tan; A D Waterman; E Y Zavala; J R Rodrigue Journal: Am J Transplant Date: 2015-02-03 Impact factor: 8.086
Authors: Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg Journal: Transplantation Date: 2017-08 Impact factor: 4.939
Authors: A Hart; J M Smith; M A Skeans; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; A Kucheryavaya; M Woodbury; J J Snyder; B L Kasiske; A K Israni Journal: Am J Transplant Date: 2017-01 Impact factor: 8.086
Authors: Linda M O'Keeffe; Anna Ramond; Clare Oliver-Williams; Peter Willeit; Ellie Paige; Patrick Trotter; Jonathan Evans; Jonas Wadström; Michael Nicholson; Dave Collett; Emanuele Di Angelantonio Journal: Ann Intern Med Date: 2018-01-30 Impact factor: 25.391
Authors: Vincent Dupont; Anders H Berg; Michifumi Yamashita; Chengqun Huang; Ambart E Covarrubias; Shafat Ali; Aleksandr Stotland; Jennifer E Van Eyk; Belinda Jim; Ravi Thadhani; S Ananth Karumanchi Journal: J Clin Invest Date: 2022-10-17 Impact factor: 19.456